XGene Podcast
Technical context you can carry with you.
Focused conversations on regulatory strategy, CMC, GMP, quality systems, inspection readiness, and evidence-driven execution. Only approved public audio sources are presented.
EXPERT AUDIOEvidence → judgment → action
CMCQUALITYINSPECTION
VOICE
LIVE CONTEXTWhat does the evidence mean for the next decision?Expert interpretation, not just summary.
01QuestionFrame the issue
02EvidenceSource + context
03JudgmentPractical meaning
Episodes
Listen when a conversation fits the question better than a document.
Archived review records remain excluded until an approved audio destination is configured.
Program in preparation
No public podcast episodes are released yet.
The podcast system is ready without exposing archived review records or substituting placeholder audio. Use XGene Articles and Regulatory Intelligence for current public analysis.
Related analysis
Continue from conversation into the source evidence and technical analysis.
ArticleThe ICH Q11 Three-Part Justification — What FDA and EMA Require for Starting Material Designation and Where Programs Fall ShortThe starting material designation in a drug substance synthesis is one of the highest-stakes decisions in small molecule CMC development — and…Read analysis →
ArticleFDA Inspection Front Room Protocol — What to Say and What Not ToThe most consequential decisions during an FDA inspection are not made in the laboratory or on the manufacturing floor — they are…Read analysis →
ArticleSalt and Co-Crystal Selection: CMC Documentation of Pharmaceutical Form Decisions in Module 3Salt selection is the first CMC decision that determines whether your drug will be manufacturable, stable, and bioavailable — and it is…Read analysis →